🇺🇸 FDA
Patent

US 10550081

Crystalline freebase forms of a biphenyl compound

granted A61KA61K31/4545A61K45/06

Quick answer

US patent 10550081 (Crystalline freebase forms of a biphenyl compound) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623